T

TScan Therapeutics Inc
NASDAQ:TCRX

Watchlist Manager
TScan Therapeutics Inc
NASDAQ:TCRX
Watchlist
Price: 2.97 USD 1.37% Market Closed
Market Cap: 158.5m USD
Have any thoughts about
TScan Therapeutics Inc?
Write Note

Income Statement

Earnings Waterfall
TScan Therapeutics Inc

Revenue
9.4m USD
Operating Expenses
-128.8m USD
Operating Income
-119.5m USD
Other Expenses
8.2m USD
Net Income
-111.3m USD

Income Statement
TScan Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
1
N/A
3
+186%
6
+91%
8
+36%
10
+25%
11
+10%
12
+11%
13
+8%
14
+2%
17
+28%
16
-5%
17
+3%
21
+24%
15
-30%
12
-18%
9
-23%
Operating Income
Operating Expenses
(27)
(32)
(40)
(50)
(59)
(68)
(74)
(75)
(80)
(91)
(99)
(108)
(115)
(117)
(124)
(129)
Selling, General & Administrative
(7)
(8)
(10)
(12)
(14)
(16)
(18)
(19)
(20)
(24)
(25)
(26)
(26)
(26)
(27)
(28)
Research & Development
(21)
(24)
(30)
(38)
(45)
(52)
(56)
(57)
(60)
(67)
(74)
(81)
(88)
(91)
(97)
(100)
Operating Income
(26)
N/A
(29)
-9%
(34)
-18%
(42)
-26%
(49)
-15%
(57)
-17%
(61)
-8%
(62)
-1%
(67)
-7%
(73)
-10%
(83)
-13%
(91)
-10%
(93)
-3%
(102)
-9%
(112)
-9%
(119)
-7%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
1
1
2
4
5
7
8
Pre-Tax Income
(26)
N/A
(29)
-9%
(34)
-18%
(42)
-26%
(49)
-15%
(57)
-17%
(61)
-8%
(62)
-1%
(66)
-7%
(73)
-10%
(82)
-12%
(88)
-8%
(89)
-1%
(97)
-9%
(104)
-8%
(111)
-7%
Net Income
Income from Continuing Operations
(26)
(29)
(34)
(42)
(49)
(57)
(61)
(62)
(66)
(73)
(82)
(88)
(89)
(97)
(104)
(111)
Net Income (Common)
(26)
N/A
(29)
-9%
(34)
-18%
(42)
-26%
(49)
-15%
(57)
-17%
(61)
-8%
(62)
-1%
(66)
-7%
(73)
-10%
(82)
-12%
(88)
-8%
(89)
-1%
(97)
-9%
(104)
-8%
(111)
-7%
EPS (Diluted)
-1.11
N/A
-1.21
-9%
-1.42
-17%
-1.79
-26%
-2.06
-15%
-2.39
-16%
-2.54
-6%
-2.57
-1%
-2.75
-7%
-3.01
-9%
-1.72
+43%
-0.93
+46%
-1.36
-46%
-1.02
+25%
-0.92
+10%
-0.93
-1%

See Also

Discover More